Morgan Stanley
DCTH icon

Morgan Stanley’s Delcath Systems DCTH Stock Holding History

Morgan Stanley’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.14M Buy
407,983
+22,459
+6% +$248K ﹤0.01% 4205
2026
Q1 		$3.58M Buy
385,524
+76,974
+25% +$746K ﹤0.01% 4368
2025
Q4 		$3.12M Buy
308,550
+55,535
+22% +$552K ﹤0.01% 4512
2025
Q3 		$2.72M Sell
253,015
-204,425
-45% -$2.28M ﹤0.01% 4592
2025
Q2 		$6.22M Buy
457,440
+114,309
+33% +$1.59M ﹤0.01% 3869
2025
Q1 		$4.37M Buy
343,131
+171,109
+99% +$2.43M ﹤0.01% 4039
2024
Q4 		$2.07M Buy
172,022
+65,546
+62% +$692K ﹤0.01% 4675
2024
Q3 		$961K Buy
106,476
+3,343
+3% +$29K ﹤0.01% 5066
2024
Q2 		$863K Buy
103,133
+8,339
+9% +$52.8K ﹤0.01% 5050
2024
Q1 		$452K Buy
94,794
+11,800
+14% +$50.9K ﹤0.01% 5358
2023
Q4 		$345K Buy
82,994
+9,652
+13% +$31.6K ﹤0.01% 5479
2023
Q3 		$297K Buy
73,342
+12,416
+20% +$58.2K ﹤0.01% 5404
2023
Q2 		$355K Buy
60,926
+17,115
+39% +$107K ﹤0.01% 5384
2023
Q1 		$252K Buy
43,811
+1,488
+4% +$6.61K ﹤0.01% 5600
2022
Q4 		$152K Sell
42,323
-317
-0.7% -$971 ﹤0.01% 5780
2022
Q3 		$136K Sell
42,640
-10,352
-20% -$41.9K ﹤0.01% 5921
2022
Q2 		$211K Buy
52,992
+9,208
+21% +$47.1K ﹤0.01% 5869
2022
Q1 		$280K Sell
43,784
-12,655
-22% -$84.9K ﹤0.01% 5730
2021
Q4 		$437K Sell
56,439
-16,396
-23% -$155K ﹤0.01% 5622
2021
Q3 		$760K Buy
72,835
+13,593
+23% +$134K ﹤0.01% 5236
2021
Q2 		$747K Buy
59,242
+12,602
+27% +$144K ﹤0.01% 5250
2021
Q1 		$580K Buy
46,640
+43,102
+1,218% +$794K ﹤0.01% 5065
2020
Q4 		$63K Sell
3,538
-2,546
-42% -$34.9K ﹤0.01% 6080
2020
Q3 		$71K Buy
6,084
+6,083
+608,300% +$68K ﹤0.01% 5577
2020
Q2 		$0 Buy
+1
New +$8 ﹤0.01% 6622

Other funds holding DCTH

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Morgan Stanley's DCTH Position: Q2 2026 in Review

Morgan Stanley increased its Delcath Systems (DCTH) stake by 5.8% in Q2 2026, buying an estimated $248K and bringing the position to 407,983 shares worth $5.14M. The position accounts for ﹤0.01% of the portfolio, ranked #4205.

Morgan Stanley first reported a position in DCTH in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.22M in Q2 2025. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • Morgan Stanley held 407,983 shares of Delcath Systems worth $5.14M as of Q2 2026.
  • Morgan Stanley bought 22,459 Delcath Systems shares in Q2 2026, an estimated $248K.
  • Delcath Systems made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4205 holding.
  • Morgan Stanley first reported a position in Delcath Systems in Q2 2020 and has held it in 25 quarters since.
  • Morgan Stanley's Delcath Systems position peaked at $6.22M in Q2 2025.
  • 120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.